Publications for Mark Gillies
Publications for Mark Gillies
2016
Fraser-Bell, S., Lim, L., Campain, A., Mehta, H.,
Aroney, C., Bryant, J., Li, J., Quin, G.,
McAllister, I., Gillies, M. (2016). Bevacizumab
or Dexamethasone Implants for DME: 2-year
Results (The BEVORDEX Study).
Ophthalmology, 123(6), 1399-1401. <a
href="http://dx.doi.org/10.1016/j.ophtha.2015.12
.012">[More Information]</a>
Xu, C., Zhu, L., Chan, T., Lu, X., Shen, W.,
Madigan, M., Gillies, M., Zhou, F. (2016).
Chloroquine and Hydroxychloroquine Are Novel
Inhibitors of Human Organic Anion Transporting
Polypeptide 1A2. Journal of Pharmaceutical
Sciences, 105(2), 884-890. <a
href="http://dx.doi.org/10.1002/jps.24663">[Mor
e Information]</a>
Kaidonis, G., Craig, J., Gillies, M., Abhary, S.,
Essex, R., Chang, J., Pal, B., Pefkianaki, M.,
Daniell, M., Lake, S., et al (2016). Promoter
polymorphism at the tumour necrosis
factor/lymphotoxin-alpha locus is associated
with type of diabetes but not with susceptibility
to sight-threatening diabetic retinopathy.
Diabetes and Vascular Disease Research, 13(2),
164-167. <a
href="http://dx.doi.org/10.1177/1479164115616
902">[More Information]</a>
Zheng, L., Gillies, M., Martin, F. (2016). Reply.
Journal of American Association for Pediatric
Ophthalmology and Strabismus, 20(2), 187-188.
<a
href="http://dx.doi.org/10.1016/j.jaapos.2016.01.
005">[More Information]</a>
2015
Zheng, L., Gillies, M., Martin, F. (2015). Central
retinal vein occlusion in an otherwise healthy
child treated successfully with a single injection
of bevacizumab. Journal of American
Association for Pediatric Ophthalmology and
Strabismus, 19(5), 473-474. <a
href="http://dx.doi.org/10.1016/j.jaapos.2015.04.
012">[More Information]</a>
Kaidonis, G., Burdon, K., Gillies, M., Abhary,
S., Essex, R., Chang, J., Pal, B., Pefkianaki, M.,
Daniell, M., Lake, S., Jenkins, A., et al (2015).
Common Sequence Variation in the VEGFC
Gene Is Associated with Diabetic Retinopathy
and Diabetic Macular Edema. Ophthalmology,
122(9), 1828-1836. <a
href="http://dx.doi.org/10.1016/j.ophtha.2015.05
.004">[More Information]</a>
Coorey, N., Shen, W., Zhu, L., Gillies, M.
(2015). Differential Expression of IL-6/gp130
Cytokines, Jak-STAT Signalling and
Neuroprotection After Muller Cell Ablation in a
Transgenic Mouse Model. Investigative
Ophthalmology & Visual Science, 56(4),
2151-2161. <a
href="http://dx.doi.org/10.1167/iovs.14-15695">
[More Information]</a>
Zhu, L., Shen, W., Lyons, B., Wang, Y., Zhou,
F., Gillies, M. (2015). Dysregulation of
inter-photoreceptor retinoid-binding protein
(IRBP) after induced Muller cell disruption.
Journal of Neurochemistry, 133(6), 909-918. <a
href="http://dx.doi.org/10.1111/jnc.13075">[Mo
re Information]</a>
Burdon, K., Fogarty, R., Shen, W., Abhary, S.,
Kaidonis, G., Appukuttan, B., Hewitt, A.,
Sharma, S., Daniell, M., Essex, R., Jenkins, A.,
Gillies, M., et al (2015). Genome-wide
association study for sight-threatening diabetic
retinopathy reveals association with genetic
variation near the GRB2 gene. Diabetologia,
58(10), 2288-2297. <a
href="http://dx.doi.org/10.1007/s00125-015-369
7-2">[More Information]</a>
Chung, S., Shen, W., Gillies, M. (2015).
Genomic Analysis Using Affymetrix Standard
Microarray GeneChips (169 Format) in
Degenerate Murine Retina. In Laura Lossi,
Adalberto Merighi (Eds.), Neuronal Cell Death:
Methods and Protocols, (pp. 129-140). New
York: Springer Science+Business Media. <a
href="http://dx.doi.org/10.1007/978-1-4939-215
2-2_10">[More Information]</a>
Chan, T., Zhu, L., Madigan, M., Wang, K., Shen,
W., Gillies, M., Zhou, F. (2015). Human organic
anion transporting polypeptide 1A2 (OATP1A2)
mediates cellular uptake of all-trans-retinol in
human retinal pigmented epithelial cells. British
Journal of Pharmacology, 172(9), 2343-2353. <a
href="http://dx.doi.org/10.1111/bph.13060">[Mo
re Information]</a>
Gillies, M., Campain, A., Barthelmes, D.,
Simpson, J., Arnold, J., Guymer, R., McAllister,
I., Essex, R., Morlet, N., Hunyor, A. (2015).
Long-Term Outcomes of Treatment of
Neovascular Age-Related Macular Degeneration:
Data from an Observational Study.
Ophthalmology, 122(9), 1837-1845. <a
href="http://dx.doi.org/10.1016/j.ophtha.2015.05
.010">[More Information]</a>
Gillies, M., Mehta, H., Bird, A. (2015). Macular
telangiectasia type 2 without clinically detectable
vasculopathy. JAMA Ophthalmology, 133(8),
951-954. <a
href="http://dx.doi.org/10.1001/jamaophthalmol.
2015.1796">[More Information]</a>
Barthelmes, D., Walton, R., Campain, A.,
Simpson, J., Arnold, J., McAllister, I., Guymer,
R., Hunyor, A., Essex, R., Morlet, N., Gillies, M.
Publications for Mark Gillies
(2015). Outcomes of persistently active
neovascular age-related macular degeneration
treated with VEGF inhibitors: Observational
study data. The British Journal of
Ophthalmology, 99(3), 359-364. <a
href="http://dx.doi.org/10.1136/bjophthalmol-20
14-305514">[More Information]</a>
Au, C., Fardell, N., Williams, M., Fraser-Bell, S.,
Campain, A., Gillies, M. (2015). Patient
experiences in retinal trials: a cross-sectional
study. BMC Ophthalmology, 15(1), 1-7. <a
href="http://dx.doi.org/10.1186/s12886-015-007
1-6">[More Information]</a>
Mehta, H., Gillies, M., Fraser-Bell, S. (2015).
Perspective on the role of Ozurdex
(dexamethasone intravitreal implant) in the
management of diabetic macular oedema.
Therapeutic Advances in Chronic Diseases, 6(5),
234-245. <a
href="http://dx.doi.org/10.1177/2040622315590
319">[More Information]</a>
Chung, S., Gillies, M., Sugiyama, Y., Zhu, L.,
Lee, S., Shen, W. (2015). Profiling of
MicroRNAs Involved in Retinal Degeneration
Caused by Selective Müller Cell Ablation. PloS
One, 10(3), 1-18. <a
href="http://dx.doi.org/10.1371/journal.pone.011
8949">[More Information]</a>
Quin, G., Lyons, B., Len, A., Madigan, M.,
Gillies, M. (2015). Proteome changes induced by
laser in diabetic retinopathy. Clinical and
Experimental Ophthalmology, 43(2), 180-187.
<a
href="http://dx.doi.org/10.1111/ceo.12372">[Mo
re Information]</a>
Xu, C., Zhu, L., Chan, T., Lu, X., Shen, W.,
Gillies, M., Zhou, F. (2015). The altered renal
and hepatic expression of solute carrier
transporters (SLCs) in type 1 diabetic mice. PloS
One, 10(3), 1-14. <a
href="http://dx.doi.org/10.1371/journal.pone.012
0760">[More Information]</a>
Gillies, M., Campain, A., Walton, R., Simpson,
J., Arnold, J., Guymer, R., McAllister, I.,
Hunyor, A., Essex, R., Morlet, N., Barthelmes,
D. (2015). Time to initial clinician-reported
inactivation of neovascular age-related macular
degeneration treated primarily with ranibizumab.
Ophthalmology, 122(3), 589-594. <a
href="http://dx.doi.org/10.1016/j.ophtha.2014.10
.001">[More Information]</a>
Arnold, J., Campain, A., Barthelmes, D.,
Simpson, J., Guymer, R., Hunyor, A.,
McAllister, I., Essex, R., Morlet, N., Gillies, M.
(2015). Two-year outcomes of treat and extend"
intravitreal therapy for neovascular age-related
macular degeneration". Ophthalmology, 122(6),
1212-1219. <a
href="http://dx.doi.org/10.1016/j.ophtha.2015.02
.009">[More Information]</a>
2014
Gillies, M., Lim, L., Campain, A., Quin, G.,
Salem, W., Li, J., Goodwin, S., Aroney, C.,
McAllister, I., Fraser-Bell, S. (2014). A
Randomized Clinical Trial of Intravitreal
Bevacizumab versus Intravitreal Dexamethasone
for Diabetic Macular Edema: The BEVORDEX
Study. Ophthalmology, 121(12), 2473-2481. <a
href="http://dx.doi.org/10.1016/j.ophtha.2014.07
.002">[More Information]</a>
Gillies, M., Walton, R., Arnold, J., McAllister, I.,
Simpson, J., Hunyor, A., Guymer, R., Essex, R.,
Morlet, N., Barthelmes, D. (2014). Comparison
of outcomes from a phase 3 study of age-related
macular degeneration with a matched,
observational cohort. Ophthalmology, 121(3),
676-681. <a
href="http://dx.doi.org/10.1016/j.ophtha.2013.09
.050">[More Information]</a>
Vaze, A., Fraser-Bell, S., Gillies, M. (2014).
Consequences of long-term discontinuation of
vascular endothelial growth factor inhibitor
therapy in the patients with neovascular
age-related macular degeneration. Acta
Ophthalmologica, 92(8), e697-e698. <a
href="http://dx.doi.org/10.1111/aos.12417">[Mo
re Information]</a>
Zhang, X., Zeng, H., Bao, B., Wang, N., Gillies,
M. (2014). Diabetic macular edema: New
concepts in patho-physiology and treatment. Cell
& Bioscience, 4, 1-14. <a
href="http://dx.doi.org/10.1186/2045-3701-4-27"
>[More Information]</a>
Barthelmes, D., Zhu, L., Shen, W., Gillies, M.,
Irhimeh, M. (2014). Differential gene expression
in Lin-/VEGF-R2+ bone marrow-derived
endothelial progenitor cells isolated from
diabetic mice. Cardiovascular Diabetology,
13(1), 1-10. <a
href="http://dx.doi.org/10.1186/1475-2840-13-4
2">[More Information]</a>
Shen, W., Lee, S., Araujo, J., Chung, S., Zhu, L.,
Gillies, M. (2014). Effect of glucocorticoids on
neuronal and vascular pathology in a transgenic
model of selective Muller cell ablation. Glia,
62(7), 1110-1124. <a
href="http://dx.doi.org/10.1002/glia.22666">[Mo
re Information]</a>
Gillies, M., Walton, R., Liong, J., Arnold, J.,
McAllister, I., Morlet, N., Hunyor, A., Guymer,
R., Keeffe, J., Essex, R., Herrera-Bond, P.,
Glastonbury, B., Simpson, J., Barthelmes, D.
(2014). Efficient capture of high-quality data on
outcomes of treatment for macular diseases: The
Fight Retinal Blindness! Project. Retina, 34(1),
Publications for Mark Gillies
188-195. <a
href="http://dx.doi.org/10.1097/IAE.0b013e3182
96b271">[More Information]</a>
Kaidonis, G., Abhary, S., Daniell, M., Gillies,
M., Fogarty, R., Petrovsky, N., Jenkins, A.,
Essex, R., Chang, J., Pal, B., et al (2014).
Genetic study of diabetic retinopathy:
Recruitment methodology and analysis of
baseline characteristics. Clinical and
Experimental Ophthalmology, 42(5), 486-493.
<a
href="http://dx.doi.org/10.1111/ceo.12239">[Mo
re Information]</a>
Zhang, X., Wang, N., Schachat, A., Bao, B.,
Gillies, M. (2014). Glucocorticoids: Structure,
Signaling and Molecular Mechanisms in the
Treatment of Diabetic Retinopathy and Diabetic
Macular Edema. Current Molecular Medicine,
14(3), 376-384. <a
href="http://dx.doi.org/10.2174/1566524014666
140128114414">[More Information]</a>
Chung, S., Shen, W., Gillies, M. (2014).
Identification of a novel miRNA targeting
CD146 for suppression of angiogenesis.
Non-coding RNAs Endocrinol, 1, 28-30. <a
href="http://dx.doi.org/10.2478/micrnado-2014-0
001">[More Information]</a>
O'Day, R., Barthelmes, D., Zhu, M., Wong, T.,
McAllister, I., Arnold, J., Gillies, M. (2014).
Intraocular pressure rise is predictive of vision
improvement after intravitreal triamcinolone
acetonide for diabetic macular oedema: a
retrospective analysis of data from a randomised
controlled trial. BMC Ophthalmology, 14(1), 1-5.
<a
href="http://dx.doi.org/10.1186/1471-2415-14-1
23">[More Information]</a>
Barthelmes, D., Walton, R., Arnold, J.,
McAllister, I., Simpson, J., Campain, A.,
Hunyor, A., Guymer, R., Essex, R., Morlet, N.,
Gillies, M. (2014). Intravitreal Therapy in
Bilateral Neovascular Age-Related Macular
Degeneration. Ophthalmology, 121(10),
2073-2074. <a
href="http://dx.doi.org/10.1016/j.ophtha.2014.05
.007">[More Information]</a>
Shibeeb, O., Vaze, A., Gillies, M., Gray, T.
(2014). Macular oedema in idiopathic macular
telangiectasia type 1 responsive to aflibercept but
not bevacizumab. Case Reports in
Ophthalmological Medicine, 2014, 1-4. <a
href="http://dx.doi.org/10.1155/2014/219792">[
More Information]</a>
Tan, M., McAllister, I., Gillies, M., Verma, N.,
Banerjee, G., Smithies, L., Wong, W., Wong, T.
(2014). Randomized controlled trial of
intravitreal ranibizumab versus standard grid
laser for macular edema following branch retinal
vein occlusion. American Journal of
Ophthalmology, 157(1), 237-247. <a
href="http://dx.doi.org/10.1016/j.ajo.2013.08.01
3">[More Information]</a>
Vaze, A., Fraser-Bell, S., Gillies, M. (2014).
Reasons for discontinuation of intravitreal
vascular endothelial growth factor inhibitors in
neovascular age-related macular degeneration.
Retina, 34(9), 1774-1778. <a
href="http://dx.doi.org/10.1097/IAE.0000000000
000173">[More Information]</a>
O'Day, R., Walton, R., Blennerhassett, R.,
Gillies, M., Barthelmes, D. (2014). Reporting of
harms by randomised controlled trials in
ophthalmology. British Journal of
Ophthalmology, 98(8), 1003-1008. <a
href="http://dx.doi.org/10.1136/bjophthalmol-20
13-304687">[More Information]</a>
Shen, W., Chung, S., Irhimeh, M., Li, S., Lee, S.,
Gillies, M. (2014). Systemic Administration of
Erythropoietin Inhibits Retinopathy in RCS Rats.
PloS One, 9(8), e104759. <a
href="http://dx.doi.org/10.1371/journal.pone.010
475">[More Information]</a>
Finger, R., Guymer, R., Gillies, M., Keeffe, J.
(2014). The Impact of Anti-Vascular Endothelial
Growth Factor Treatment on Quality of Life in
Neovascular Age-related Macular Degeneration.
Ophthalmology, 121(6), 1246-1251. <a
href="http://dx.doi.org/10.1016/j.ophtha.2013.12
.032">[More Information]</a>
2013
Zhu, L., Shen, W., Zhu, M., Coorey, N., Nguyen,
A., Barthelmes, D., Gillies, M. (2013).
Anti-Retinal Antibodies in Patients With
Macular Telangiectasia Type 2. Investigative
Ophthalmology and Visual Science, 54(8),
5675-5683. <a
href="http://dx.doi.org/10.1167/iovs.13-12050">
[More Information]</a>
O'Day, R., Barthelmes, D., Zhu, M., Wong, T.,
McAllister, I., Arnold, J., Gillies, M. (2013).
Baseline central macular thickness predicts the
need for retreatment with intravitreal
triamcinolone plus laser photocoagulation for
diabetic macular edema. Clinical
Ophthalmology, 7, 1565-1570. <a
href="http://dx.doi.org/10.2147/OPTH.S47424">
[More Information]</a>
Liew, G., Quin, G., Gillies, M., Fraser-Bell, S.
(2013). Central serous chorioretinopathy: a
review of
epidemiology and pathophysiology. Clinical and
Experimental Ophthalmology, 41(2), 201-214.
<a
href="http://dx.doi.org/10.1111/j.1442-9071.201
2.02848.x">[More Information]</a>
Publications for Mark Gillies
Barthelmes, D., Irhimeh, M., Gillies, M.,
Karimipour, M., Zhou, M., Zhu, L., Shen, W.
(2013). Diabetes impairs mobilization of mouse
bone marrow-derived Lin-/VEGF-R2+
progenitor cells. Blood Cells, Molecules and
Diseases, 51(3), 163-173. <a
href="http://dx.doi.org/10.1016/j.bcmd.2013.05.
002">[More Information]</a>
Zhang, X., Wang, N., Barile, G., Bao, B., Gillies,
M. (2013). Diabetic retinopathy: Neuron
protection as a therapeutic target. The
International Journal of Biochemistry and Cell
Biology, 45(7), 1525-1529. <a
href="http://dx.doi.org/10.1016/j.biocel.2013.03.
002">[More Information]</a>
Quin, G., Liew, G., Ho, I., Gillies, M.,
Fraser-Bell, S. (2013). Diagnosis and
interventions for central serous
chorioretinopathy: review and update. Clinical
and Experimental Ophthalmology, 41(2),
187-200. <a
href="http://dx.doi.org/10.1111/j.1442-9071.201
2.02847.x">[More Information]</a>
Chung, S., Shen, W., Jayawardana, K., Wang, P.,
Yang, J., Shackel, N., Gillies, M. (2013).
Differential gene expression profiling after
conditional müller-cell ablation in a novel
transgenic model. Investigative Ophthalmology
and Visual Science, 54(3), 2142-2152. <a
href="http://dx.doi.org/10.1167/iovs.12-1155">[
More Information]</a>
Shen, W., Zhu, L., Lee, S., Chung, S., Gillies, M.
(2013). Involvement of NT3 and P75NTR in
photoreceptor degeneration following selective
Muller cell ablation. Journal of
Neuroinflammation, 10(137), 1-13. <a
href="http://dx.doi.org/10.1186/1742-2094-10-1
37">[More Information]</a>
Barthelmes, D., Irhimeh, M., Gillies, M., Zhu,
L., Shen, W. (2013). Isolation and
characterization of mouse bone marrow-derived
Lin−/VEGF-R2+ progenitor cells. Annals of
Hematology, 92(11), 1461-1472. <a
href="http://dx.doi.org/10.1007/s00277-013-181
5-0">[More Information]</a>
Chung, S., Shen, W., Gillies, M. (2013). Laser
Capture Microdissection-Directed Profiling of
Glycolytic and mTOR Pathways in Areas of
Selectively Ablated Muller Cells in the Murine
Retina. Investigative Ophthalmology and Visual
Science, 54(10), 6578-6584. <a
href="http://dx.doi.org/10.1167/iovs.13-12311">
[More Information]</a>
Powner, M., Gillies, M., Zhu, M., Vevis, K.,
Hunyor, A., Fruttiger, M. (2013). Loss of
Müller's cells and photoreceptors in macular
telangiectasia type 2. Ophthalmology, 120(11),
2344-2352. <a
href="http://dx.doi.org/10.1016/j.ophtha.2013.04
.013">[More Information]</a>
Issa, P., Gillies, M., Chew, E., Bird, A., Heeren,
T., Peto, T., Holz, F., Scholl, H. (2013). Macular
telangiectasia type 2. Progress in Retinal and
Eye Research, 34, 49-77. <a
href="http://dx.doi.org/10.1016/j.preteyeres.2012
.11.002">[More Information]</a>
Clemons, T., Gillies, M., Chew, E., Bird, A.,
Peto, T., Wang, J., Mitchell, P., Ramdas, W.,
Vingerling, J. (2013). Medical Characteristics of
Patients with Macular Telangiectasia Type 2
(MacTel Type 2) MacTel Project Report No. 3.
Ophthalmic Epidemiology, 20(2), 109-113. <a
href="http://dx.doi.org/10.3109/09286586.2013.
766757">[More Information]</a>
Kemp, A., Preen, D., Morlet, N., CLARK, A.,
McAllister, I., BRIFFA, T., SANFILIPPO, F.,
Ng, J., MCKNIGHT, C., REYNOLDS, W.,
Gillies, M. (2013). Myocardial infarction after
intravitreal vascular endothelial growth factor
inhibitors: A whole population study. Retina,
33(5), 920-927. <a
href="http://dx.doi.org/10.1097/IAE.0b013e3182
76e07b">[More Information]</a>
O'Day, R., Gillies, M., Ahlenstiel, G. (2013).
Ophthalmologic complications of antiviral
therapy in hepatitis C treatment. World Journal
of Gastroenterology, 19(45), 8227-8237. <a
href="http://dx.doi.org/10.3748/wjg.v19.i45.822
7">[More Information]</a>
Gillies, M., Walton, R., Simpson, J., Arnold, J.,
Guymer, R., McAllister, I., Hunyor, A., Essex,
R., Mortlet, N., Barthelmes, D. (2013).
Prospective Audit of Exudative Age-Related
Macular Degeneration: 12-month Outcomes in
Treatment-Naive eyes. Investigative
Ophthalmology and Visual Science, 54(8),
5754-5760. <a
href="http://dx.doi.org/10.1167/iovs.13-11993">
[More Information]</a>
Holz, F., Bandello, F., Gillies, M., Mitchell, P.,
Osborne, A., Sheidow, T., Souied, E., Figueroa,
M. (2013). Safety of ranibizumab in routine
clinical practice: 1-year retrospective pooled
analysis of four European neovascular AMD
registries within the LUMINOUS programme.
British Journal of Ophthalmology, 97(9),
1161-1167. <a
href="http://dx.doi.org/10.1136/bjophthalmol-20
13-303232">[More Information]</a>
Zhu, M., Krilis, M., Gillies, M. (2013). The
relationship between inner retinal cavitation,
photoreceptor disruption, and the integrity of the
outer limiting membrane in macular
telangiectasia type 2. Retina, 33(8), 1547-1550.
<a
href="http://dx.doi.org/10.1097/IAE.0b013e3182
Publications for Mark Gillies
85cb9c">[More Information]</a>
Zhang, X., Lai, D., Bao, B., Hambly, B., Gillies,
M. (2013). Triamcinolone Acetonide Inhibits
p38MAPK Activation and Neuronal Apoptosis
in Early Diabetic Retinopathy. Current
Molecular Medicine, 13(6), 946-958. <a
href="http://dx.doi.org/10.2174/1566524011313
9990066">[More Information]</a>
2012
Sallo, F., Peto, T., Egan, C., Wolf-Schnurrbusch,
U., Clemons, T., Gillies, M., Pauleikhoff, D.,
Rubin, G., Chew, E., Bird, A. (2012). "En face"
OCT imaging of the IS/OS junction line in type 2
idiopathic macular telangiectasia. Investigative
Ophthalmology and Visual Science, 53(10),
6145-6152. <a
href="http://dx.doi.org/10.1167/iovs.12-10580">
[More Information]</a>
Salem, W., Fraser-Bell, S., Gillies, M. (2012).
Clinical development of new treatments for
diabetic macular oedema. Clinical &
Experimental Optometry, 95(3), 297-305. <a
href="http://dx.doi.org/10.1111/j.1444-0938.201
2.00723.x">[More Information]</a>
Shen, W., Fruttiger, M., Zhu, L., Chung, S.,
Barnett, N., Kirk, J., Lee, S., Coorey, N.,
Killingsworth, M., Sherman, L., Gillies, M.
(2012). Conditional Muller Cell Ablation Causes
Independent
Neuronal and Vascular Pathologies in a Novel
Transgenic
Model. The Journal of Neuroscience, 32(45),
15715-15727. <a
href="http://dx.doi.org/10.1523/JNEUROSCI.28
41-12.2012">[More Information]</a>
McAllister, I., Gillies, M., Smithies, L.,
Rochtchina, E., Harper, C., Daniell, M.,
Constable, I., Mitchell, P. (2012). Factors
Promoting Success and Influencing
Complications in Laser-Induced Central Vein
Bypass. Ophthalmology, 119(12), 2579-2586. <a
href="http://dx.doi.org/10.1016/j.ophtha.2012.06
.047">[More Information]</a>
Parmalee, N., Schubert, C., Figueroa, M., Bird,
A., Peto, T., Gillies, M., Bernstein, P., Kiryluk,
K., Terwilliger, J., Allikmets, R. (2012).
Identification of a Potential Susceptibility Locus
for Macular Telangiectasia Type 2. PloS One,
7(8), 1-10. <a
href="http://dx.doi.org/10.1371/journal.pone.002
4268">[More Information]</a>
Dabirrahmani, D., Becker, S., Hogg, M.,
Appleyard, R., Baroud, G., Gillies, M. (2012).
Mechanical variables affecting balloon
kyphoplasty outcome - a finite element study.
Computer Methods in Biomechanics and
Biomedical Engineering, 15(3), 211-220. <a
href="http://dx.doi.org/10.1080/10255842.2010.
522183">[More Information]</a>
Zhu, M., Gillies, M. (2012). New insight of
clinical and laboratory aspects of macular
telangiectasia type 2. 17th Congress of Chinese
Ophthalmological Society 2012, Nanjing, China:
Chinese Ophthalmological Society.
Len, A., Powner, M., Zhu, L., Hageman, G.,
Song, X., Fruttiger, M., Gillies, M. (2012). Pilot
application of iTRAQ to the retinal disease
macular telangiectasia. Journal of Proteome
Research, 11(2), 537-553. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=22098468">[More Information]</a>
Jay, N., Gillies, M. (2012). Proteomic analysis of
ophthalmic disease. Clinical and Experimental
Ophthalmology, 40(7), 755-763. <a
href="http://dx.doi.org/10.1111/j.1442-9071.201
2.02788.x">[More Information]</a>
Sallo, F., Peto, T., Egan, C., Wolf-Schnurrbusch,
U., Clemons, T., Gillies, M., Pauleikhoff, D.,
Rubin, G., Chew, E., Bird, A. (2012). The IS/OS
Junction Layer in the Natural History of Type 2
Idiopathic Macular Telangiectasia. Investigative
Ophthalmology and Visual Science, 53(12),
7889-7895. <a
href="http://dx.doi.org/10.1167/iovs.12-10765">
[More Information]</a>
Coorey, N., Shen, W., Chung, S., Zhu, L.,
Gillies, M. (2012). The role of glia in retinal
vascular disease. Clinical & Experimental
Optometry, 95(3), 266-281. <a
href="http://dx.doi.org/10.1111/j.1444-0938.201
2.00741.x">[More Information]</a>
Zhang, X., Chen, M., Gillies, M. (2012). Two
Isoforms of Flk-1 Transcripts in Early Diabetic
Rat Retinas. Current Eye Research, 37(1), 73-79.
<a
href="http://dx.doi.org/10.3109/02713683.2011.
629766">[More Information]</a>
Cherepanoff, S., Killingsworth, M., Zhu, M.,
Nolan, T., Hunyor, A., Young, S., Hageman, G.,
Gillies, M. (2012). Ultrastructural and clinical
evidence of subretinal debris accumulation in
type 2 macular telangiectasia. British Journal of
Ophthalmology, 96(11), 1404-1409. <a
href="http://dx.doi.org/10.1136/bjophthalmol-20
11-301009">[More Information]</a>
2011
Haller, J., Bandello, F., Belfort, R.,
Blumenkranz, M., Gillies, M., Heier, J.,
Loewenstein, A., Yoon, Y., Jiao, J., Li, X., et al
(2011). Dexamethasone intravitreal implant in
patients with macular edema related to branch or
central retinal vein occlusion twelve-month study
Publications for Mark Gillies
results. Ophthalmology, 118(12), 2453-2460. <a
href="http://dx.doi.org/10.1016/j.ophtha.2011.05
.014">[More Information]</a>
3">[More Information]</a>
Becker, S., Dabirrahmani, D., Hogg, M.,
Appleyard, R., Baroud, G., Gillies, M. (2011).
Disadvantages of balloon kyphoplasty with
PMMA - A clinical and biomechanical
statement. Journal fur Mineralstoffwechsel,
18(Suppl 1), 9-12.
Parmalee, N., Schubert, C., Merriam, J.,
Allikmets, K., Bird, A., Gillies, M., Peto, T.,
Figueroa, M., Friedlander, M., Fruttiger, M., et al
(2010). Analysis of candidate genes for macular
telangiectasia type 2. Molecular Vision, 16,
2718-2726. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=21179236">[More Information]</a>
Irhimeh, M., Shen, W., Chung, S., Zhu, L.,
Barthelmes, D., Gillies, M. (2011). Erythropoetin
treatment recruits pECFCs from the marrow into
the blood and stabilizes retinal vasculature.
Experimental Hematology, 39(8), S77-S78.
Gillies, M., McAllister, I., Zhu, M., Wong, W.,
Louis, D., Arnold, J., Wong, T. (2011).
Intravitreal Triamcinolone Prior to Laser
Treatment of Diabetic Macular Edema 24-Month
Results of a Randomized Controlled Trial.
Ophthalmology, 118(5), 866-872. <a
href="http://dx.doi.org/10.1016/j.ophtha.2010.09
.029">[More Information]</a>
Len, A., Powner, M., Zhu, L., Hageman, G.,
Song, X., Fruttiger, M., Gillies, M. (2011). Pilot
Application of iTRAQ to the Retinal Disease
Macular Telangiectasia. Journal of Proteome
Research, 11(2), 537-553. <a
href="http://dx.doi.org/10.1021/pr200889t">[Mo
re Information]</a>
Fraser-Bell, S., Gillies, M. (2011). Retinal
conditions - Part 1. Australian Doctor, 22, 27-32.
Fraser-Bell, S., Gillies, M. (2011). Retinal
conditions - Part 2. Australian Doctor, 29, 25-32.
Shen, W., Zhang, J., Chung, S., Hu, Y., Ma, Z.,
Gillies, M. (2011). Submacular
DL-alpha-Aminoadipic Acid Eradicates Primate
Photoreceptors but Does Not Affect Luteal
Pigment or the Retinal Vasculature. Investigative
Ophthalmology and Visual Science, 52(1),
119-127. <a
href="http://dx.doi.org/10.1167/iovs.10-6033">[
More Information]</a>
Krilis, M., Zhu, M., Gillies, M. (2011). The
relationship between Muller Cells and
Photoreceptors in Type 2 Idiopathic Macular
Telangiectasia (MacTel). 43rd Annual Scientific
Congress of the Royal Australian and New
Zealand College of Ophthalmologists RANZCO
2011, Canberra, ACT, Australia.
Shen, W., Li, S., Chung, S., Zhu, L., Stayt, J., Su,
T., Couraud, P., Romero, I., Weksler, B., Gillies,
M. (2011). Tyrosine phosphorylation of
VE-cadherin and claudin-5 is associated with
TGF-β1-induced permeability of centrally
derived vascular endothelium. European Journal
of Cell Biology, 90(4), 323-332. <a
href="http://dx.doi.org/10.1016/j.ejcb.2010.10.01
2010
Szental, J., Baird, P., Richardson, A., Amirul
Islam, F., Scholl, H., Issa, P., Holz, F., Gillies,
M., Guymer, R. (2010). Analysis of glutathione
S-transferase Pi isoform (GSTP1)
single-nucleotide polymorphisms and macular
telangiectasia type 2. International
Ophthalmology, 30(6), 645-650. <a
href="http://dx.doi.org/10.1007/s10792-010-937
4-z">[More Information]</a>
Clemons, T., Gillies, M., Chew, E., Bird, A.,
Peto, T., Figueroa, M., Harrington, M. (2010).
Baseline characteristics of participants in the
natural history study of macular telangiectasia
(MacTel) MacTel Project Report No. 2.
Ophthalmic Epidemiology, 17(1), 66-73. <a
href="http://dx.doi.org/10.3109/0928658090345
0361">[More Information]</a>
Gillies, M. (2010). Bevacizumab in
ophthalmology: the controversy moves forward.
Clinical and Experimental Ophthalmology,
38(4), 333-334. <a
href="http://dx.doi.org/10.1111/j.1442-9071.201
0.02300.x">[More Information]</a>
Kuo, C., Gillies, M., McCluskey, P. (2010).
Intraocular Triamcinolone for Giant Cell
Arteritis? Archives of Ophthalmology, 128(12).
<a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=21149801">[More Information]</a>
Powner, M., Gillies, M., Tretiach, M., Scott, A.,
Guymer, R., Hageman, G., Fruttiger, M. (2010).
Perifoveal müller cell depletion in a case of
macular telangiectasia type 2. Ophthalmology,
117(12), 2407-2416. <a
href="http://dx.doi.org/10.1016/j.ophtha.2010.04
.001">[More Information]</a>
Kuo, C., McCluskey, P., Gillies, M. (2010).
Pharmacotherapeutic efficacy of
preservative-free intravitreal triamcinolone
acetonide. Expert Opinion on Pharmacotherapy,
11(1), 155-166. <a
href="http://dx.doi.org/10.1517/1465656090346
3885">[More Information]</a>
Gillies, M., McAllister, I., Zhu, M., Wong, W.,
Louis, D., Arnold, J., Wong, T. (2010).
Publications for Mark Gillies
Pretreatment with Intravitreal Triamcinolone
before Laser for Diabetic Macular Edema:
6-Month Results of a Randomised,
Placebo-Controlled Trial. Investigative
Ophthalmology and Visual Science, 51(5),
2322-2328. <a
href="http://dx.doi.org/10.1167/iovs.09-4400">[
More Information]</a>
Dabirrahmani, D., Hogg, M., Kohan, L., Gillies,
M. (2010). Primary and Long-Term Stability of a
Short-Stem Hip Implant. Institution of
Mechanical Engineers. Proceedings. Part H:
Journal of Engineering in Medicine, 224(9),
1109-1119. <a
href="http://dx.doi.org/10.1243/09544119JEIM7
04">[More Information]</a>
Haller, J., Bandello, F., Belfort, R.,
Blumenkranz, M., Gillies, M., Heier, J.,
Loewenstein, A., Yoon, Y., Jacques, M., Jiao, J.,
et al (2010). Randomized, sham-controlled trial
of dexamethasone intravitreal implant in patients
with macular edema due to retinal vein
occlusion. Ophthalmology, 117(6), 1134-1146.
<a
href="http://dx.doi.org/10.1016/j.ophtha.2010.03
.032">[More Information]</a>
Shen, W., Li, S., Chung, S., Gillies, M. (2010).
Retinal vascular changes after glial disruption in
rats. Journal of Neuroscience Research, 88(7),
1485-1499. <a
href="http://dx.doi.org/10.1002/jnr.22317">[Mor
e Information]</a>
McAllister, I., Gillies, M., Smithies, L.,
Rochtchina, E., Harper, C., Daniell, M.,
Constable, I., Mitchell, P. (2010). The Central
Retinal Vein Bypass Study: a trial of
laser-induced chorioretinal venous anastomosis
for central retinal vein occlusion.
Ophthalmology, 117(5), 954-965. <a
href="http://dx.doi.org/10.1016/j.ophtha.2009.10
.026">[More Information]</a>
Gillies, M., Islam, F., Larsson, J., Pasadhika, S.,
Gaston, C., Zhu, M., Wong, T. (2010).
Triamcinolone-induced cataract in eyes with
diabetic macular oedema: 3-year prospective
data from a randomized clinical trial. Clinical
and Experimental Ophthalmology, 38(6),
605-612. <a
href="http://dx.doi.org/10.1111/j.1442-9071.201
0.02341.x">[More Information]</a>
2009
Cherepanoff, S., McMenamin, P., Gillies, M.,
Kettle, E., Sarks, S. (2009). Bruch's membrane
and choroidal macrophages in early and
advanced age-related macular degeneration.
British Journal of Ophthalmology, 94(7),
918-925. <a
href="http://dx.doi.org/10.1136/bjo.2009.165563
">[More Information]</a>
Gillies, M. (2009). Diabetic macular edema.
Ophthalmology, 116(3), 595; author reply 596-7.
<a
href="http://dx.doi.org/10.1016/j.ophtha.2008.12
.016">[More Information]</a>
Gillies, M., Zhu, M., Chew, E., Barthelmes, D.,
Hughes, E., Ali, H., Holz, F., Scholl, H., Issa, P.
(2009). Familial Asymptomatic Macular
Telangiectasia Type 2. Ophthalmology, 116(12),
2422-2429. <a
href="http://dx.doi.org/10.1016/j.ophtha.2009.05
.010">[More Information]</a>
Gillies, M., Simpson, J., Gaston, C., Hunt, G.,
Ali, H., Zhu, M., Sutter, F. (2009). Five-year
results of a randomized trial with open-label
extension of triamcinolone acetonide for
refractory diabetic macular edema.
Ophthalmology, 116(11), 2182-2187. <a
href="http://dx.doi.org/10.1016/j.ophtha.2009.04
.049">[More Information]</a>
Gillies, M., Simpson, J., Zhu, M., Hunt, G., Ali,
H., Gaston, C. (2009). Intravitreal triamcinolone.
Ophthalmology, 116(3), 591. <a
href="http://dx.doi.org/10.1016/j.ophtha.2008.09
.044">[More Information]</a>
Tikellis, G., Gillies, M., Guymer, R., McAllister,
I., Shaw, J., Wong, T. (2009). Retinal vascular
caliber and macular telangiectasia type 2.
Ophthalmology, 116(2), 319-323. <a
href="http://dx.doi.org/10.1016/j.ophtha.2008.09
.009">[More Information]</a>
Kuo, C., Gillies, M. (2009). Role of steroids in
the treatment of diabetic macular edema.
International Ophthalmology Clinics, 49(2),
121-134. <a
href="http://dx.doi.org/10.1097/IIO.0b013e3181
9fcce8">[More Information]</a>
Zhang, X., Bao, B., Hambly, B., Gillies, M.
(2009). Vascular endothelial growth factor-A: A
multifunctional molecular player in diabetic
retinopathy. The International Journal of
Biochemistry and Cell Biology, 41(12),
2368-2371. <a
href="http://dx.doi.org/10.1016/j.biocel.2009.07.
011">[More Information]</a>
2008
Fischer, M., Fleischhauer, J., Gillies, M., Sutter,
F., Helbig, H., Barthelmes, D. (2008). A new
method to monitor visual field defects caused by
photoreceptor degeneration by quantitative
optical coherence tomography. Investigative
Ophthalmology and Visual Science, 49(8),
3617-3621. <a
href="http://dx.doi.org/10.1167/iovs.08-2003">[
More Information]</a>
Publications for Mark Gillies
Mitchell, P., Gillies, M., Wang, J. (2008). Author
reply. Ophthalmology, 11, 214.
Barthelmes, D., Sutter, F., Gillies, M. (2008).
Differential optical densities of intraretinal
spaces. Investigative Ophthalmology and Visual
Science, 49(8), 3529-3534. <a
href="http://dx.doi.org/10.1167/iovs.07-1320">[
More Information]</a>
Hughes, E., Zhu, M., Barthelmes, D., Ali, H.,
Issa, P., Gillies, M. (2008). Familial
Asymptomatic Macular Telangiectasia Type 2.
40th Annual Scientific Congress of the Royal
Australian and New Zealand College of
Ophthalmologists RANZCO 2008, Melbourne,
VIC, Australia.
Liew, G., Gillies, M., Wang, J. (2008).
Fenofibrate and diabetic retinopathy. The Lancet,
371(9614), 721-721. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=18313494">[More Information]</a>
Zhang, X., Bao, B., Lai, D., Rapkins, R., Gillies,
M. (2008). Intravitreal Triamcinolone Acetonide
Inhibits Breakdown of the Blood-Retinal Barrier
through Differential Regulation of VEGF-A and
its Receptors in Early Diabetic Rat Retinas.
Diabetes, 57(4), 1026-1033. <a
href="http://dx.doi.org/10.2337/db07-0982">[M
ore Information]</a>
Barthelmes, D., Gillies, M., Sutter, F. (2008).
Quantitative OCT analysis of idiopathic
perifoveal telangiectasia. Investigative
Ophthalmology and Visual Science, 49(5),
2156-2162. <a
href="http://dx.doi.org/10.1167/iovs.07-0478">[
More Information]</a>
Larsson, J., Kifley, A., Zhu, M., Wang, J.,
Mitchell, P., Sutter, F., Gillies, M. (2008). Rapid
reduction of hard exudates in eyes with diabetic
retinopathy after intravitreal triamcinolone: data
from a randomized, placebo-controlled, clinical
trial. Acta Ophthalmologica, 87(3), 275-280. <a
href="http://dx.doi.org/10.1111/j.1755-3768.200
8.01245.x">[More Information]</a>
Wickremasinghe, S., Rogers, S., Gillies, M.,
Zhu, M., Wong, T. (2008). Retinal vascular
caliber changes after intravitreal triamcinolone
treatment for diabetic macular edema.
Investigative Ophthalmology and Visual Science,
49(11), 4707-4711. <a
href="http://dx.doi.org/10.1167/iovs.08-1678">[
More Information]</a>
Sliesoraityte, I., Tikellis, G., Wang, J., Mitchell,
P., Gillies, M., Wong, T. (2008). Retinal vessel
diameter and diabetic macular edema.
Investigative Ophthalmology and Visual Science,
on line(May).
Gillies, M. (2008). Surrogate marker.
Ophthalmology, 115(2), 416-417; author reply
417. <a
href="http://dx.doi.org/10.1016/j.ophtha.2007.08
.020">[More Information]</a>
Clemons, T., Gillies, M., Chew, E., Bird, A.,
Peto, T., Figueroa, M., Harrington, M., MacTel
Research Group, T. (2008). The National Eye
Institute Visual Function Questionnaire in the
macular telangiectasia (MacTel) project.
Investigative Ophthalmology and Visual Science,
49(10), 4340-4346. <a
href="http://dx.doi.org/10.1167/iovs.08-1749">[
More Information]</a>
Gillies, M. (2008). The role of intravitreal
steroids in the management of diabetic
retinopathy. In Elia J Duh (Eds.), Diabetic
Retinopathy, (pp. 435-448). USA: Humana
Press.
McGimpsey, S., Gillies, M. (2008). Treatment of
macular degeneration--controversy and hope.
British Journal of Ophthalmology, 92(3),
436-437. <a
href="http://dx.doi.org/10.1136/bjo.2007.125070
">[More Information]</a>
2007
Barthelmes, D., Gillies, M., Fleischhauer, J.,
Sutter, F. (2007). A case of idiopathic perifoveal
Telangiectasia preceded by features of cone
dystrophy. Eye, 21(12), 1534-1535. <a
href="http://dx.doi.org/10.1038/sj.eye.6702985"
>[More Information]</a>
Gillies, M., Hogg, M., Kohan, L., Cordingley, R.
(2007). Adaptive bone remodelling of all
polyethylene unicompartmental tibial bearings.
ANZ Journal of Surgery, 77(1- 2), 69-72. <a
href="http://dx.doi.org/10.1111/j.1445-2197.200
6.03980.x">[More Information]</a>
Sutter, F., Gillies, M., Helbig, H. (2007).
Diabetic Macular Edema Current Treatments.
In Holz F; Spaide R (Eds.), Medical Retina, (pp.
131-146). Germany: Springer.
Gillies, M., Amirul Islam, F., Zhu, M., Larsson,
J., Wong, T. (2007). Efficacy and safety of
multiple intravitreal triamcinolone injections for
refractory diabetic macular oedema. British
Journal of Ophthalmology, 91(10), 1323-1326.
<a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17405800">[More Information]</a>
Mohamed, Q., Gillies, M., Wong, T. (2007).
Management of diabetic retinopathy - A
systematic review. JAMA: The Journal of the
American Medical Association, 298(8), 902-916.
<a
href="http://dx.doi.org/10.1001/jama.298.8.902"
Publications for Mark Gillies
>[More Information]</a>
Quin, G., Len, A., Billson, F., Gillies, M. (2007).
Proteome map of normal rat retina and
comparison with the proteome of diabetic rat
retina: New insight in the pathogenesis of
diabetic retinopathy. Proteomics, 7(15),
2636-2650. <a
href="http://dx.doi.org/10.1002/pmic.200600486
">[More Information]</a>
Gillies, M., Wong, T. (2007). Ranibizumab for
neovascular age-related macular degeneration.
The New England Journal of Medicine, 356(7),
748-750. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17310523">[More Information]</a>
Gillies, M., Larsson, J. (2007). The effect of
intravitreal triamcinolone on foveal edema in
exudative macular degeneration. American
Journal of Ophthalmology, 144(1), 134-136. <a
href="http://dx.doi.org/10.1016/j.ajo.2007.03.01
9">[More Information]</a>
2006
Zhu, M., Gillies, M., Amirul Islam, F., Larsson,
J., Wong, T. (2006). Efficacy and safety of
multiple intravitreal triamcinolone injections for
refractory diabetic macular oedema. AOVS
Annual Meeting 2006.
Sirimaharaj, M., Robinson, M., Zhu, M., Csaky,
K., Donovan, B., Sutter, F., Gillies, M. (2006).
Intravitreal injection of triamcinolone acetonide
for immune recovery uveitis. Retina: the Journal
of Retinal and Vitreous Diseases, 26(5),
578-580. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16770266">[More Information]</a>
Gillies, M., Sutter, F., Simpson, J., Larsson, J.,
Ali, H., Zhu, M. (2006). Intravitreal
Triamcinolone for Refractory Diabetic Macular
Edema Two-Year Results of a Double-Masked,
Placebo-Controlled, Randomized Clinical Trial.
Ophthalmology, 113(9), 1533-1538. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16828501">[More Information]</a>
Chew, E., Gillies, M., Bird, A. (2006). Macular
telangiectasia: a simplified classification.
Archives of Ophthalmology, 124(4), 573-574. <a
href="http://dx.doi.org/10.1001/archopht.124.4.5
73">[More Information]</a>
Cherepanoff, S., Mitchell, P., Wang, J., Gillies,
M. (2006). Retinal autoantibody profile in early
age-related macular degeneration: preliminary
findings from the Blue Mountains Eye Study.
Clinical and Experimental Ophthalmology,
34(6), 590-5. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16925708">[More Information]</a>
Gillies, M., Simpson, J., Zhu, M. (2006).
Triamcinolone for occult exudative age-related
macular degeneration. American Journal of
Ophthalmology, 141(1), 228. <a
href="http://dx.doi.org/10.1016/j.ajo.2005.07.06
4">[More Information]</a>
Gillies, M. (2006). What we don't know about
avastin might hurt us. Archives of
Ophthalmology, 124(10), 1478-1479.
2005
Gillies, M., Zhu, M., Simpson, J., Sutter, F.
(2005). A randomized, placebo-controlled trial of
intravitreal triamcinolone acetonide for diabetic
macularedema that persists or recurs after laser
treatment – 2 year results. ARVO Annual Meeting
2005.
Zhu, M., Larsson, J., El Jamal, H., Gillies, M.
(2005). Correlation between intraocular pressure,
visual acuity and reduction of foveal thickness in
diabetic macular oedema treated with intravitreal
Triamcinolone. ARVO Annual Meeting 2005.
Larssor, J., Wong, J., Kifley, A., Mitchell, P.,
Sutter, F., Zhu, M., Gillies, M. (2005). Effect of
intravitreal Triamcinolone on hard exudates in
patients with diabetic retinopathy - a pilot,
randomized controlled clinical trial. ARVO
Annual Meeting 2005.
Tretiach, M., Madigan, M., Wen, L., Gillies, M.
(2005). Effect of Müller cell co-culture on in
vitro permeability of bovine retinal vascular
endothelium in normoxic and hypoxic
conditions. Neuroscience Letters, 378(3),
160-165. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15781151">[More Information]</a>
Gillies, M., Kuzniarz, M., Craig, J., Ball, M.,
Luo, W., Simpson, J. (2005). Intravitreal
triamcinolone-induced elevated intraocular
pressure is associated with the development of
posterior subcapsular cataract. Ophthalmology,
112(1), 139-143. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15629834">[More Information]</a>
Wang, Y., Li, S., Zhu, M., Chen, S., Liu, Y.,
Men, X., Gillies, M., Larsson, J. (2005).
Metamorphopsia after successful retinal
detachment surgery: an optical coherence
tomography study. Acta Ophthalmologica
Scandinavica, 83(2), 168-171. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15799727">[More Information]</a>
Publications for Mark Gillies
Zhu, M., Gillies, M., Larsson, J., Sutter, F.
(2005). Relation between reduction of foveal
thickness and visual acuity in diabetic macular
edema treated with intravitreal triamcinolone.
American Journal of Ophthalmology, 139(5),
802-6. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15860283">[More Information]</a>
Larsson, J., Gillies, M. (2005). Severe loss of
vision after removal of cataract caused by
intravitreal triamcinolone in combination with
photodynamic therapy for exudative age-related
macular degeneration. Clinical and Experimental
Ophthalmology, 33(5), 544-5. <a
href="http://dx.doi.org/10.1111/j.1442-9071.200
5.01082.x">[More Information]</a>
2004
Tretiach, M., Madigan, M., Gillies, M. (2004).
Conditioned Medium From Mixed Retinal
Pigmented Epithelium And M?Ller Cell Cultures
Reduces In Vitro Permeability Of Retinal
Vascular Endothelial Cells. British Journal of
Ophthalmology, 88(7), 957-961.
Gillies, M., Simpson, J., Sutter, F., Simpson, J.
(2004). Intravitreal Triamcinolone For Diabetic
Macular Edema That Persists After Laser
Treatment: Three-Month Efficacy And Safety
Results Of A Prospective, Randomized,
Double-Masked, Placebo-Controlled Clinical
Trial. Ophthalmology, 111(11), 2044-2049.
Gillies, M., Simpson, J., Billson, F., Luo, W.,
Penfold, P., Chua, W., Mitchell, P., Zhu, M.,
Hunyor, A. (2004). Safety Of An Intravitreal
Injection Of Triamcinolone: Results From A
Randomized Clinical Trial. Archives of
Ophthalmology, 122(3), 336-340.
2003
Gillies, M., Simpson, J., Luo, W., Penfold, P.,
Hunyor, A., Chua, W., Mitchell, P., Billson, F.
(2003). A randomized clinical trial of a single
dose of intravitreal Triamcinolone Acetonide for
Neovascular age-related macular
degeneration;one year results. Archives of
Ophthalmology, 121, 667-673. <a
href="http://dx.doi.org/10.1001/archopht.121.5.6
67">[More Information]</a>
Sutter, F., Gillies, M. (2003). Intravitreal
triamcinolone for radiation-induced macular
edema. Archives of Ophthalmology, 11,
1491-1492. <a
href="http://dx.doi.org/10.1001/archopht.121.10.
1491">[More Information]</a>
Sutter, F., Gillies, M. (2003).
Pseudo-endophthalmitis after intravitreal
injection of triamcinolone. British Journal of
Ophthalmology, 87(8), 972-974.
Zhu, M., Gillies, M., Kuzniarz, M., Hunyor, B.,
Luo, W. (2003). Safety of a second intravitreal
injection of triamcinolone. Australian
Ophthalmic and Visual Sciences Meeting
(Melbourne 2003).
Wang, J., Mitchell, P., Smith, W., Gillies, M.,
Billson, F. (2003). Systemic use of
ani-inflammatory medications and age-related
maculopathy: The Blue Mountains Eye Study.
Ophthalmic Epidemiology, 10(1), 37-48.
van Reyk, D., Gillies, M., Davies, M. (2003).
The retina: oxidative stress and diabetes. Redox
Report, 8(4), 187-192.
Tretiach, M., Van Driel, D., Gillies, M. (2003).
Transendothelial electrical resistance of bovine
retinal capillary endothelial cells is influenced by
cell growth patterns: an ultrastructural study.
Clinical and Experimental Ophthalmology,
31(4), 348-353.
2001
Penfold, P., Madigan, M., Gillies, M., Provis, J.
(2001). Immunological and aetiological aspects
of macular degeneration. Progress in Retinal and
Eye Research, 20, 385-414.